Galera Therapeutics (GRTX) Expected to Announce Earnings on Monday

Galera Therapeutics (NASDAQ:GRTX) is projected to release its results before the market opens on Monday, May 11th. Analysts expect Galera Therapeutics to post earnings of ($0.8313) per share for the quarter.

Galera Therapeutics Price Performance

NASDAQ:GRTX traded up $0.01 during mid-day trading on Monday, reaching $0.10. The stock had a trading volume of 136,189 shares, compared to its average volume of 245,609. Galera Therapeutics has a 12 month low of $0.02 and a 12 month high of $0.15. The stock has a market capitalization of $7.55 million, a PE ratio of -0.29 and a beta of 2.63. The stock has a 50-day simple moving average of $0.06 and a two-hundred day simple moving average of $0.03.

Galera Therapeutics Company Profile

Galera Therapeutics, Inc is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania. The company focuses on developing precision medicines designed to address oxidative stress and inflammation in pulmonary and rare diseases. Galera’s proprietary platform centers on small-molecule prodrugs of glutathione and related thiol compounds intended to enhance intracellular antioxidant defenses.

Galera’s lead product candidate is an inhaled glutathione prodrug currently in early-stage clinical trials for acute lung injury and acute respiratory distress syndrome.